IMMUNOCORE HLDGS PLC
IMCR·45258D105·US·ADR·Healthcare - Biotechnology-13D/G
IMCR (IMMUNOCORE HLDGS PLC) is held by 81 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($146.8M), FMR LLC ($145.6M), WELLINGTON MANAGEMENT GROUP LLP ($141.9M). Net institutional sentiment: Mixed.
81
Holders
Avg rating(21 Elite)
$976.8M
Total Value
54% (91)
Fund Consensus
43 buying - 37 selling
Who's Trading
ActivistVPVestal Point Capital, LP5.5%May 15, 2026
ActivistTRT. Rowe Price Investment Management, Inc.3.7%May 15, 2026
InsiderJBJallal BahijaSell $371KFeb 18, 2026
InsiderBMBerman David MSell $193KFeb 18, 2026
InsiderSASt Leger Tina AmberSell $32KFeb 18, 2026
InsiderGJGOLL JOHNSell $23KFeb 18, 2026
InsiderBMBerman David MSell $23KDec 5, 2025
InsiderBMBerman David MSell $1.3MDec 4, 2025
InsiderBMBerman David MSell $221KNov 28, 2025
InsiderBMBerman David MSell $2.8MNov 26, 2025
13F: Insider & Congress:
Showing 1-20 of 91
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer